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Neutrophilic polymorphonuclearleukocytes (PMNs) have been implicated in the
capillarywall injury in glomerulonephritis (GN) via release ofproteinasesand reac-
tiveoxygen species(1, 2). Although the acid proteinase cathepsin B can degrade iso-
lated glomerularbasement membrane (GBM) invitro(3), moststudies suggest that
the major PMN proteinases that degrade GBM are the cationic neutral serine pro-
teinases elastase and cathepsinG, and theneutralmetalloproteinase gelatinase (3-5).
Despite the impressive in vitro data supporting a role for PMN-derived proteinases
in GBM injury, very little in vivoevidence ofsuch a mechanism has been provided.
We report here on the ability of elastase and cathepsin G to mediate glomerular
injury in vivo.
Volume 168 September 1988 1169-1174
Materials and Methods
BriefDefinitive Report
Reagents.
￿
Elastase andcathepsin Gwere isolated from humanPMNs (6) andassayed using
the specific synthetic peptide substrates methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanalide
(MSAAPVNA) (Sigma Chemical Co., St. Louis, MO) and N-succinyl-Ala-Ala-Pro-Phe
p-nitroanilide (Sigma Chemical Co.), respectively. The specific activity of the elastase and
cathepsin Gwas 130 and 36 U/pg protein, respectively, where 1 U caused achange in absor-
banceof0.001/min at 400 nm and25°C. Neitherthe cathepsinGnorelastase substratereacted
with theotherenzyme preparation. In some experiments, elastase and cathepsin Gwere irre-
versibly inactivated with the specific chloromethyl-ketone inhibitors MSAAPVchloromethyl
ketone (MSAAPVCK)(Sigma Chemical Co.) and Z-Gly-Leu-Phe-chloromethyl ketone (En-
zyme SystemsProducts, Livermore, CA). Elastase andinactivated elastase were equivalently
cationic (pI > 10.5) by isoelectric focusing.
Renal Artery Perfusion.
￿
Sprague-Dawley rats were anesthetized with chloral hydrate, and
a left nephrectomy was performed. The aorta was clamped and the right renal artery was
perfused at a flow rate of 0.5 ml/min as described (7). Initially, 0.5 ml PBS was perfused
to displace blood from the kidney. Rats were then perfused with 50 ltg of active (n = 13)
or inactivated elastase (n = 6) in 0.5 ml PBS. Control rats received PBS alone (n = 15).
These studieswere presented in part at the 20th Annual MeetingoftheAmerican SocietyofNephrology
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Additional rats (n = 19) were perfused with smaller amounts of active elastase (1-25 pg) to
establish a dose-response relationship, and four rats received 1 mg of cationized IgG (pI 8.1-
> 9.3) (8). Finally, some rats received either active (n = 8) or inactivated cathepsin G (n =
4). After an additional 4 min, the kidney was cleared with 0.3 ml of PBS, and blood flow
was restored. Only kidneys that reperfused normally were included in the study, and total
ischemia time was always <8 min. After recovery from anesthesia, the rat was placed in a
metabolic cage with free access to water.
Localization ofElastase.
￿
In separate experiments, elastase was localized by immunofluores-
cence using anti-elastase antibody raised in New Zealand rabbits. Elastase (n = 3), or inac-
tive elastase (n = 3) (dose; 50 pg) was perfused as described above, but was followed by 0.5
ml PBS and then 1 ml of PBS containing 40 mg of anti-elastase rabbit IgG. Control rats
received elastase followed by 40 mg of normal rabbit IgG (n = 2) or PBS followed by anti-
elastase antibody (n = 2). 10 min after reperfusion, the kidney was biopsied and sections
were stained for rabbit IgG with FITC-conjugated goat anti-rabbit IgG (Cappel Laborato-
ries, Malvern, PA) as described (7).
To quantify the binding ofelastase to the glomerulus, rats were perfused with 50 pg trace-
labeled '25I-elastase (n = 4) or "'I-inactive elastase (n = 4) as described above, followed by
9 ml of PBS to remove unbound 1251 . The elastase, labeled with 1251 by the chloramine T
method, remained enzymatically active. The kidney was removed, the glomeruli isolated (7),
and the uptake of
1251 measured with a gamma counter. The total amount of elastase bound
per glomerulus was calculated from the specific activity ofthe injected active or inactive elastase.
For comparison, the amount of elastase released by human PMNs (10'/ml) was measured
after a 2-min preincubation with 5 pg/ml cytochalasin B (Aldrich Chemical Co., Milwaukee,
WI) followed by a 20-min incubation with 10- ' M FMLP (Peninsula Laboratories, Inc., Bel-
mont, CA) (n = 4). Cells were centrifuged at 1,000 g for 5 min, and the supernatant was
assayed for elastase activity.
Morphologic Studies.
￿
After perfusion with 50 pg of active or inactive elastase, kidney biop-
sies (n = 30) were performed at 10 min, 2, 24, and 48 h. Two rats that received elastase
were also biopsied at 4 and 9 d. No individual rat had more than three biopsies. Kidney
biopsies were also performed on all rats perfused with active or inactive cathepsin G 24 h
after perfusion. Tissue for light and electron microscopy was processed as described (7), and
sections for light microscopy were stained with periodic acid Schiff reagent.
Statistical Analysis.
￿
All data shown are mean ± SE. Analysis between groups was per-
formed using the Student's t test.
Results
Proteinuria After Elastase Perfusion.
￿
The infusion of 50 gg of active elastase into the
renal artery of rats resulted in massive proteinuria that was not seen in control rats
that received inactive elastase or PBS alone (Table I). In most rats, the proteinuria
resolved in 2-3 d, but in three rats, it persisted for 6-9 d (i.e., >40 mg/24 h). Four
rats perfused with large doses (i .e., 1 mg) of cationized human IgG failed to develop
the degree of proteinuria that was observed in the elastase-perfused animals (Table
1). In most studies, the elastase was allowed to remain in the ischemic kidney for
4 min before reperfusion. However, three elastase-perfused rats, in whom the blood
flow was immediately restored, developed impressive proteinuria in the initial 24 h
after surgery (163 t 57 mg/24 h), suggesting that the delay in reperfusion was not
essential for injury. A linear relationship between the dose of elastase infused and
the degree of proteinuria was noted (no elastase, 15 ± 3 mg/24 h, n = 15; 5 gg
elastase, 3 mg/24 h, n = 2; 10 wg elastase, 33 ± 4 mg, n = 4; 15 ug elastase, 40
t 5 mg, n = 5 ; 20 gg elastase, 82 t 51 mg, n = 4; 25 pg elastase, 77 ± 22 mg,
n = 4; 50 gg elastase, 196 ± 32 mg, n = 13; r = 0.7 by linear regression, p < 0.001).JOHNSON ET AL .
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TABLE I
Urinary Protein Excretion (mg/24 h) after Renal Artery
Perfusion of Various Perfusates
p < 0.005, relative to other groups .
$ p < 0.05, relative to other groups .
The threshold dose of elastase that was necessary to induce significant proteinuria
was 10-15 pg .
Glomerular Localization of Elastase .
￿
The infused elastase was localized in the
glomerulus by fluorescent staining of a rabbit antibody to elastase administered in
vivo (Fig . 1 A) . Inactivated elastase, which has a similar isoelectric point, also local-
ized to the glomerular capillary wall (Fig . 1 B) . Neither control rats receiving elastase
followed by normal rabbit IgG nor rats given PBS and anti-elastase antibody had
any detectable rabbit IgG in their glomeruli . The infusion of 50 pg of 1251-elastase
or 1251-inactive elastase resulted in comparable binding to glomeruli (324 ± 82
pg/glomerulus vs . 318 ± 67 pg/glomerulus, p = NS), indicating that inactivation
of elastase did not affect the degree ofglomerular binding . Human PMNs pretreated
with cytochalasin B released .3.3 ug elastase/106 PMNs on incubation with 10 -1 M
f-met-leu-phe . Given our observation that the renal artery perfusion of 50 ug elastase
results in the binding of 324 pg elastase/glomerulus, it can be calculated that the
amount of elastase that is present in an individual glomerulus in rats perfused with
50 ug elastase could theoretically be provided locally by 100 human PMNs.
FIGURE 1 .
￿
The infusion ofelastase (A) or inactive elastase (B) into the renal artery ofrats results
in its localization to the glomerular capillary wall as demonstrated by immunofluorescence using
a rabbit antibody to elastase (x 400) .
Perfusate Day 0-1
n
Day 1-2
n
Elastase (50 pg) 196 t 32 (13)' 42 ± 121 (8)
Inactive elastase (50 pg) 19 t 2 (6) 8 t 1 (s)
PBS 15 t 3 (15) ND
Cationized IgG (1 mg) 25 t 11 (4) 12 t 3 (3)
Values are mean t SE .1172
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FIGURE 2 .
￿
Glomerulus of a rat 24 h after the renal artery was perfused with 50 Ag of active
elastase . The endothelium is intact, the GBM is of normal thickness, and there is preservation
ofepithelial cell foot processes .No inflammatory cells are evident. (CL, capillarylumen ; M, mesan-
gial cell ; R, red blood cell) (x 18,500).
Morphology ofElastaseperfused Rats.
￿
Light microscopy was performed on elastase
and inactive elastase-perfused rats at multiple times after perfusion (10 min, 2, 24,
48 h, 4, and9d) . At no time wasproliferation ofresident glomerular cells or infiltra-
tion by blood-borne inflammatory cells seen . TheGBMwasalways of normal thick-
ness anddidnot display any gaps or splitting. Atday 9, there were occasional glomeruli
that had focal mesangial areas with decreased nuclear staining.
EM was performed on elastase-perfused rats at 10 min, 2, 24 (Fig . 2), and 48 h,
and on days 4 and 9 . No increase in mesangial matrix or cell number was noted .
Glomerular endothelial cells displayed no evidence of injury or proliferation, and
the GBM appeared normal . Epithelial cell foot processes remained largely intact
with only focal areas of fusion noted. There was no evidence of neutrophil, mono-
cyte, or platelet infiltration, and fibrin deposition was absent .
Effect ofCathepsinGInfusion.
￿
The renal artery perfusion of50 wg of active cathepsin
G was associated with marked proteinuria that was not observed in control rats
receiving inactivated cathepsinG (228 t 25 mg vs . 23 t 2 mg/24 h, p< 0.001).
The administration of 5 wg of cathepsinG did not induce proteinuria (24 t 3 mg/
24 h, n = 4) . Light microscopy performed on cathepsin G perfused rats at 24 h
(n = 4) was not different from the controls receiving inactive cathepsinG (n = 4) .
There was no proliferation, and only an occasionalPMN was observed . TheGBM
was of normal thickness and without gaps or splitting . EM was not performed .
Discussion
These studies provide the first direct evidence that the humanPMN serine pro-
teinases, elastase and cathepsin G, can mediateGBMinjury andproteinuria in vivo.JOHNSON ET AL.
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The infusion of elastase resulted in its localization to the glomerular capillary walls
possibly via charge interactions between elastase, which is cationic (pI > 10), and
the rich anionic sites present in GBM. Quantitative binding studies demonstrated
that the amount of elastase bound per glomerulus after perfusion of a proteinuric
dose of 20 ug could be provided by 40 humanPMNs. The averagenumber of PMNs
per glomerulus in human GN varies greatly, but in certain diseases may be as many
as 17 per 6 gm glomerular cross-section (9). Therefore, it is likely that the amount
of elastase (and possibly cathepsin G) bound to our rat glomeruli could have been
released locally by PMNs in human GN. These estimates are approximate, since
PMNs attracted to glomeruli in vivo would not be expected to release all of their
elastase or cathepsin G. However, the concentration of the proteinases at the site
of degranulation (i.e., in the space between an adherent PMN and GBM) would
be expected to be high. In addition, proteinases released into this microenviron-
ment may be protected from plasma inhibitors (e.g., a-l-proteinase inhibitor and
a-2-macroglobulin) (10). In our studies, inactivation by plasma inhibitors was
minimized by perfusion into a bloodless kidney.
The observation that the proteinuria in our studies was in the nephrotic range
is highly suggestive of an injury to the glomerular capillary wall resulting in an in-
crease in its permeability. It is of interest, therefore, that the glomeruli appeared
to be normal histologically. Even epithelial cell foot process fusion, which is observed
in almost all severely proteinuric states, was absent. In contrast, the perfusion of
the isolated components of the myeloperoxidase (MPO)-H202-halide system into
the renal artery results in proteinuria and marked histologic injury characterized
initially by endothelial cell damage, platelet influx, and focal epithelial cell foot pro-
cess fusion, and later (i .e., 4-10 d) by a proliferation of resident glomerular cells (11,
12). Sincethe release by the PMN of both proteinases and components of the MPO
system wouldbe anticipated within the glomeruli in PMN-dependent GN, it is likely
that both would contribute to the injury observed, with the proteinases primarily
causingchanges in permeability and the MPO-derived oxidants producingchanges
in permeability and also mediating cellular damage.
We do not believe that the proteinuria observed in ourelastase-perfused rats was
secondary to charge neutralization of the glomerular capillary wall. The infusion
of much larger (i.e., 20 times) quantities of cationized IgG did not reproduce the
degree of proteinuric, nor did inactive elastase, although the latter is as cationic
as native elastase. The fact that the proteinuria could not be reproduced by inacti-
vated proteinases strongly suggests that the observed effects were due to proteolytic
activity. The mechanism responsible for the proteinuria most likely involves degra-
dation of basement membrane. Elastase and cathepsin G can degrade many base-
ment membrane proteins, including type IV collagen, fibronectin, and the protein
core ofvarious proteoglycans (13). Although these proteinases can also injure or affect
the function of various cell types (13), we did not observe any histologic evidence
for endothelial cell injury or inflammatory cell involvement.
Summary
We infused microgram quantities of active or inactive PMNelastase and cathepsin
G into the renal arteries of rats. Both active and inactive elastase localized to the
glomerular capillary wall equally, and in amounts that could be achieved physiologi-117 4
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cally in GN . However, elastase-perfused rats developed marked proteinuria (196 ±
32 mg/24h) compared with control rats receiving inactive elastase (19 ± 2 mg/24 h,
p < 0.005). Similar results were seen with active and inactive cathepsin G. Neither
elastase nor cathepsin G infusion was associated with histologic evidence of glomer-
ular injury. We conclude that the PMN neutral serine proteinases elastase and cathepsin
G can mediate marked changes in glomerular permeability in vivo due to their pro-
teolytic activity, and thus, may contribute to the proteinuria observed in PMN-
dependent models of GN .
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